Trial NCT03019588

View at ClinicalTrials.gov 
Org. Study IDs: 3475-063
Secondary IDs: MK-3475-063

Last trial update was posted on 2023-03-30

MeSH Interventions

Paclitaxel Pembrolizumab

MeSH Conditions

Adenocarcinoma Esophageal Neoplasms Stomach Neoplasms

Other Conditions

Gastric Neoplasms Gastroesophageal Junction Adenocarcinoma

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID